FDA Inspection 1163246 — Omega Alpha Pharmaceuticals

Omega Alpha Pharmaceuticals — FEI 3010129381

The FDA completed an inspection of Omega Alpha Pharmaceuticals on February 24, 2022 in Scarborough. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 24, 2022
Fiscal Year
2022
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Scarborough (Canada)

Citations

IDCFRDescription
1543421 CFR 111.15(d)(2)Pest control measures
1576221 CFR 111.205(a)Master manufacturing record - each batch
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1587221 CFR 111.75(c)(3)Specifications met identity,purity, strength, comp,; basis
446421 CFR 108.25(c)(1)Registration
447021 CFR 108.25(c)(2)Process filing
451121 CFR 108.25(f)Approved school